SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001437749-23-012831
Filing Date
2023-05-05
Accepted
2023-05-05 16:30:47
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D/A bhat20230502_sc13da.htm SC 13D/A 31669
  Complete submission text file 0001437749-23-012831.txt   33063
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Subject) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-90624 | Film No.: 23894362
SIC: 2834 Pharmaceutical Preparations

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address
Bhat Laxminarayan (Filed by) CIK: 0001818245 (see all company filings)

Type: SC 13D/A